 | • レポートコード：GIR-105X03928 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、凝固因子IXのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。凝固因子IXの種類別市場規模（凝固因子IX（血漿由来）、凝固因子IX（組換え））、用途別市場規模（大人、子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・凝固因子IXの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、CSL Behring、Grifols、Novo Nordisk、Bioverativ、Sanquin、Takeda、Baxter、Aptevo ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：凝固因子IX（血漿由来）、凝固因子IX（組換え） ・用途別分析2016年-2026年：大人、子供 ・凝固因子IXの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・凝固因子IXのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・凝固因子IXのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・凝固因子IXの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・凝固因子IXの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Coagulation Factor IX market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Coagulation Factor IX size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Coagulation Factor IX market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Coagulation Factor IX market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Market segment by Application can be divided into
Adult
Kids
The key market players for global Coagulation Factor IX market are listed below:
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Coagulation Factor IX product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Coagulation Factor IX, with price, sales, revenue and global market share of Coagulation Factor IX from 2019 to 2021.
Chapter 3, the Coagulation Factor IX competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Coagulation Factor IX breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Coagulation Factor IX market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Coagulation Factor IX sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Coagulation Factor IX Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Coagulation Factor IX Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Coagulation Factor IX (Plasma Derived)
1.2.3 Coagulation Factor IX (Recombinant)
1.3 Market Analysis by Application
1.3.1 Overview: Global Coagulation Factor IX Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adult
1.3.3 Kids
1.4 Global Coagulation Factor IX Market Size & Forecast
1.4.1 Global Coagulation Factor IX Sales in Value (2016-2026))
1.4.2 Global Coagulation Factor IX Sales in Volume (2016-2026)
1.4.3 Global Coagulation Factor IX Price by Type (2016-2026) & (USD/Unit)
1.5 Global Coagulation Factor IX Production Capacity Analysis
1.5.1 Global Coagulation Factor IX Total Production Capacity (2016-2026)
1.5.2 Global Coagulation Factor IX Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Coagulation Factor IX Market Drivers
1.6.2 Coagulation Factor IX Market Restraints
1.6.3 Coagulation Factor IX Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Coagulation Factor IX Product and Services
2.1.4 Pfizer Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 CSL Behring
2.2.1 CSL Behring Details
2.2.2 CSL Behring Major Business
2.2.3 CSL Behring Coagulation Factor IX Product and Services
2.2.4 CSL Behring Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Coagulation Factor IX Product and Services
2.3.4 Grifols Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Coagulation Factor IX Product and Services
2.4.4 Novo Nordisk Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Bioverativ
2.5.1 Bioverativ Details
2.5.2 Bioverativ Major Business
2.5.3 Bioverativ Coagulation Factor IX Product and Services
2.5.4 Bioverativ Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sanquin
2.6.1 Sanquin Details
2.6.2 Sanquin Major Business
2.6.3 Sanquin Coagulation Factor IX Product and Services
2.6.4 Sanquin Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business
2.7.3 Takeda Coagulation Factor IX Product and Services
2.7.4 Takeda Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Baxter
2.8.1 Baxter Details
2.8.2 Baxter Major Business
2.8.3 Baxter Coagulation Factor IX Product and Services
2.8.4 Baxter Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Aptevo
2.9.1 Aptevo Details
2.9.2 Aptevo Major Business
2.9.3 Aptevo Coagulation Factor IX Product and Services
2.9.4 Aptevo Coagulation Factor IX Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Coagulation Factor IX Sales by Manufacturer
3.1 Global Coagulation Factor IX Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Coagulation Factor IX Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Coagulation Factor IX
3.4 Market Concentration Rate
3.4.1 Top 3 Coagulation Factor IX Manufacturer Market Share
3.4.2 Top 6 Coagulation Factor IX Manufacturer Market Share
3.5 Global Coagulation Factor IX Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Coagulation Factor IX Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Coagulation Factor IX Market Size by Region
4.1.1 Global Coagulation Factor IX Sales in Volume by Region (2016-2026)
4.1.2 Global Coagulation Factor IX Revenue by Region (2016-2026)
4.2 North America Coagulation Factor IX Revenue (2016-2026)
4.3 Europe Coagulation Factor IX Revenue (2016-2026)
4.4 Asia-Pacific Coagulation Factor IX Revenue (2016-2026)
4.5 South America Coagulation Factor IX Revenue (2016-2026)
4.6 Middle East and Africa Coagulation Factor IX Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Coagulation Factor IX Sales in Volume by Type (2016-2026)
5.2 Global Coagulation Factor IX Revenue by Type (2016-2026)
5.3 Global Coagulation Factor IX Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Coagulation Factor IX Sales in Volume by Application (2016-2026)
6.2 Global Coagulation Factor IX Revenue by Application (2016-2026)
6.3 Global Coagulation Factor IX Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Coagulation Factor IX Sales by Type (2016-2026)
7.2 North America Coagulation Factor IX Sales by Application (2016-2026)
7.3 North America Coagulation Factor IX Market Size by Country
7.3.1 North America Coagulation Factor IX Sales in Volume by Country (2016-2026)
7.3.2 North America Coagulation Factor IX Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Coagulation Factor IX Sales by Type (2016-2026)
8.2 Europe Coagulation Factor IX Sales by Application (2016-2026)
8.3 Europe Coagulation Factor IX Market Size by Country
8.3.1 Europe Coagulation Factor IX Sales in Volume by Country (2016-2026)
8.3.2 Europe Coagulation Factor IX Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Coagulation Factor IX Sales by Type (2016-2026)
9.2 Asia-Pacific Coagulation Factor IX Sales by Application (2016-2026)
9.3 Asia-Pacific Coagulation Factor IX Market Size by Region
9.3.1 Asia-Pacific Coagulation Factor IX Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Coagulation Factor IX Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Coagulation Factor IX Sales by Type (2016-2026)
10.2 South America Coagulation Factor IX Sales by Application (2016-2026)
10.3 South America Coagulation Factor IX Market Size by Country
10.3.1 South America Coagulation Factor IX Sales in Volume by Country (2016-2026)
10.3.2 South America Coagulation Factor IX Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Coagulation Factor IX Sales by Type (2016-2026)
11.2 Middle East & Africa Coagulation Factor IX Sales by Application (2016-2026)
11.3 Middle East & Africa Coagulation Factor IX Market Size by Country
11.3.1 Middle East & Africa Coagulation Factor IX Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Coagulation Factor IX Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Coagulation Factor IX Typical Distributors
12.3 Coagulation Factor IX Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Coagulation Factor IX Revenue by Type, (USD Million), 2021-2026
Table 2. Global Coagulation Factor IX Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Coagulation Factor IX Product and Services
Table 6. Pfizer Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 8. CSL Behring Major Business
Table 9. CSL Behring Coagulation Factor IX Product and Services
Table 10. CSL Behring Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Grifols Basic Information, Manufacturing Base and Competitors
Table 12. Grifols Major Business
Table 13. Grifols Coagulation Factor IX Product and Services
Table 14. Grifols Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 16. Novo Nordisk Major Business
Table 17. Novo Nordisk Coagulation Factor IX Product and Services
Table 18. Novo Nordisk Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bioverativ Basic Information, Manufacturing Base and Competitors
Table 20. Bioverativ Major Business
Table 21. Bioverativ Coagulation Factor IX Product and Services
Table 22. Bioverativ Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sanquin Basic Information, Manufacturing Base and Competitors
Table 24. Sanquin Major Business
Table 25. Sanquin Coagulation Factor IX Product and Services
Table 26. Sanquin Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Takeda Basic Information, Manufacturing Base and Competitors
Table 28. Takeda Major Business
Table 29. Takeda Coagulation Factor IX Product and Services
Table 30. Takeda Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Baxter Basic Information, Manufacturing Base and Competitors
Table 32. Baxter Major Business
Table 33. Baxter Coagulation Factor IX Product and Services
Table 34. Baxter Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Aptevo Basic Information, Manufacturing Base and Competitors
Table 36. Aptevo Major Business
Table 37. Aptevo Coagulation Factor IX Product and Services
Table 38. Aptevo Coagulation Factor IX Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Coagulation Factor IX Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Coagulation Factor IX Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Coagulation Factor IX, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Coagulation Factor IX Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Coagulation Factor IX Production Site of Key Manufacturer
Table 44. Coagulation Factor IX New Entrant and Capacity Expansion Plans
Table 45. Coagulation Factor IX Mergers & Acquisitions in the Past Five Years
Table 46. Global Coagulation Factor IX Sales by Region (2016-2021e) & (K Units)
Table 47. Global Coagulation Factor IX Sales by Region (2021-2026) & (K Units)
Table 48. Global Coagulation Factor IX Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Coagulation Factor IX Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Coagulation Factor IX Sales by Type (2016-2021e) & (K Units)
Table 51. Global Coagulation Factor IX Sales by Type (2021-2026) & (K Units)
Table 52. Global Coagulation Factor IX Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Coagulation Factor IX Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Coagulation Factor IX Price by Type (2016-2021e) & (USD/Unit)
Table 55. Global Coagulation Factor IX Price by Type (2021-2026) & (USD/Unit)
Table 56. Global Coagulation Factor IX Sales by Application (2016-2021e) & (K Units)
Table 57. Global Coagulation Factor IX Sales by Application (2021-2026) & (K Units)
Table 58. Global Coagulation Factor IX Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Coagulation Factor IX Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Coagulation Factor IX Price by Application (2016-2021e) & (USD/Unit)
Table 61. Global Coagulation Factor IX Price by Application (2021-2026) & (USD/Unit)
Table 62. North America Coagulation Factor IX Sales by Country (2016-2021e) & (K Units)
Table 63. North America Coagulation Factor IX Sales by Country (2021-2026) & (K Units)
Table 64. North America Coagulation Factor IX Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Coagulation Factor IX Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Coagulation Factor IX Sales by Type (2016-2021e) & (K Units)
Table 67. North America Coagulation Factor IX Sales by Type (2021-2026) & (K Units)
Table 68. North America Coagulation Factor IX Sales by Application (2016-2021e) & (K Units)
Table 69. North America Coagulation Factor IX Sales by Application (2021-2026) & (K Units)
Table 70. Europe Coagulation Factor IX Sales by Country (2016-2021e) & (K Units)
Table 71. Europe Coagulation Factor IX Sales by Country (2021-2026) & (K Units)
Table 72. Europe Coagulation Factor IX Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Coagulation Factor IX Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Coagulation Factor IX Sales by Type (2016-2021e) & (K Units)
Table 75. Europe Coagulation Factor IX Sales by Type (2021-2026) & (K Units)
Table 76. Europe Coagulation Factor IX Sales by Application (2016-2021e) & (K Units)
Table 77. Europe Coagulation Factor IX Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific Coagulation Factor IX Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific Coagulation Factor IX Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific Coagulation Factor IX Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Coagulation Factor IX Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Coagulation Factor IX Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific Coagulation Factor IX Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific Coagulation Factor IX Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific Coagulation Factor IX Sales by Application (2021-2026) & (K Units)
Table 86. South America Coagulation Factor IX Sales by Country (2016-2021e) & (K Units)
Table 87. South America Coagulation Factor IX Sales by Country (2021-2026) & (K Units)
Table 88. South America Coagulation Factor IX Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Coagulation Factor IX Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Coagulation Factor IX Sales by Type (2016-2021e) & (K Units)
Table 91. South America Coagulation Factor IX Sales by Type (2021-2026) & (K Units)
Table 92. South America Coagulation Factor IX Sales by Application (2016-2021e) & (K Units)
Table 93. South America Coagulation Factor IX Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa Coagulation Factor IX Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa Coagulation Factor IX Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa Coagulation Factor IX Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Coagulation Factor IX Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Coagulation Factor IX Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa Coagulation Factor IX Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa Coagulation Factor IX Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa Coagulation Factor IX Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Coagulation Factor IX Typical Distributors
Table 105. Coagulation Factor IX Typical Customers
List of Figures
Figure 1. Coagulation Factor IX Picture
Figure 2. Global Coagulation Factor IX Sales Market Share by Type in 2020
Figure 3. Coagulation Factor IX (Plasma Derived)
Figure 4. Coagulation Factor IX (Recombinant)
Figure 5. Global Coagulation Factor IX Sales Market Share by Application in 2020
Figure 6. Adult
Figure 7. Kids
Figure 8. Global Coagulation Factor IX Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Coagulation Factor IX Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Coagulation Factor IX Sales (2016-2026) & (K Units)
Figure 11. Global Coagulation Factor IX Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Coagulation Factor IX Production Capacity (2016-2026) & (K Units)
Figure 13. Global Coagulation Factor IX Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Coagulation Factor IX Market Drivers
Figure 15. Coagulation Factor IX Market Restraints
Figure 16. Coagulation Factor IX Market Trends
Figure 17. Global Coagulation Factor IX Sales Market Share by Manufacturer in 2020
Figure 18. Global Coagulation Factor IX Revenue Market Share by Manufacturer in 2020
Figure 19. Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Coagulation Factor IX Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Coagulation Factor IX Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Coagulation Factor IX Sales Market Share by Region (2016-2026)
Figure 23. Global Coagulation Factor IX Revenue Market Share by Region (2016-2026)
Figure 24. North America Coagulation Factor IX Revenue (2016-2026) & (USD Million)
Figure 25. Europe Coagulation Factor IX Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Coagulation Factor IX Revenue (2016-2026) & (USD Million)
Figure 27. South America Coagulation Factor IX Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Coagulation Factor IX Revenue (2016-2026) & (USD Million)
Figure 29. Global Coagulation Factor IX Sales Market Share by Type (2016-2026)
Figure 30. Global Coagulation Factor IX Revenue Market Share by Type (2016-2026)
Figure 31. Global Coagulation Factor IX Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Coagulation Factor IX Sales Market Share by Application (2016-2026)
Figure 33. Global Coagulation Factor IX Revenue Market Share by Application (2016-2026)
Figure 34. Global Coagulation Factor IX Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Coagulation Factor IX Sales Market Share by Type (2016-2026)
Figure 36. North America Coagulation Factor IX Sales Market Share by Application (2016-2026)
Figure 37. North America Coagulation Factor IX Sales Market Share by Country (2016-2026)
Figure 38. North America Coagulation Factor IX Revenue Market Share by Country (2016-2026)
Figure 39. United States Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Coagulation Factor IX Sales Market Share by Type (2016-2026)
Figure 43. Europe Coagulation Factor IX Sales Market Share by Application (2016-2026)
Figure 44. Europe Coagulation Factor IX Sales Market Share by Country (2016-2026)
Figure 45. Europe Coagulation Factor IX Revenue Market Share by Country (2016-2026)
Figure 46. Germany Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Coagulation Factor IX Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Coagulation Factor IX Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Coagulation Factor IX Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Coagulation Factor IX Revenue Market Share by Region (2016-2026)
Figure 55. China Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Coagulation Factor IX Sales Market Share by Type (2016-2026)
Figure 62. South America Coagulation Factor IX Sales Market Share by Application (2016-2026)
Figure 63. South America Coagulation Factor IX Sales Market Share by Country (2016-2026)
Figure 64. South America Coagulation Factor IX Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Coagulation Factor IX Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Coagulation Factor IX Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Coagulation Factor IX Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Coagulation Factor IX Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Coagulation Factor IX Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
凝固VIIa因子の世界市場2018-2025 This study researches the market size of Coagulation Factor VIIa, presents the global Coagulation Factor VIIa sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of Coagulation F…- 組み換え凝固因子の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents. Scope of the Report: This report studies th…
- 血漿由来第VIII因子の世界市場2018-2025 This study researches the market size of Plasma-derived Factor VIII, presents the global Plasma-derived Factor VIII sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of Plasma-…
- 組換え抗血友病因子の世界市場2018-2025 This study researches the market size of Recombinant Antihemophilic Factor, presents the global Recombinant Antihemophilic Factor sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data informat…
- 世界の凝固分析装置市場 2021：企業別、地域別、種類・用途別 The Coagulation Analysers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…